These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1687114)
1. Synthesis and anxiolytic activity of N-substituted cyclic imides (1R*,2S*,3R*,4S*)-N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,3- bicyclo[2.2.1]heptanedicarboximide (tandospirone) and related compounds. Ishizumi K; Kojima A; Antoku F Chem Pharm Bull (Tokyo); 1991 Sep; 39(9):2288-300. PubMed ID: 1687114 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of new N-[4-(4-aryl- and 4-heteroaryl-1-piperazinyl)butyl]derivatives of 1-methyl-5-oxobicyclo[2.2.1]heptane-2,3-dicarboximide with an expected anxiolytic activity. Kossakowski J; Zawadowski T; Kuśmierczyk J Acta Pol Pharm; 1998; 55(4):315-8. PubMed ID: 9821397 [TBL] [Abstract][Full Text] [Related]
3. Polycyclic aryl- and heteroarylpiperazinyl imides as 5-HT1A receptor ligands and potential anxiolytic agents: synthesis and structure-activity relationship studies. Abou-Gharbia M; Patel UR; Webb MB; Moyer JA; Andree TH; Muth EA J Med Chem; 1988 Jul; 31(7):1382-92. PubMed ID: 2898533 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and anxiolytic activity of N-substituted cyclic imides N-[4-[(4-aryl)-1-piperazinyl]alkyl]-5,7-dioxabicyclo[2.2.2]octane-2, 3-dicarboximide. Zawadowski T; Kossakowski J; Rump S; Jakowicz I; Płaźnik A Acta Pol Pharm; 1995; 52(1):43-6. PubMed ID: 8960237 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XVI. Derivatives of 1-acetoxy-7,7-dimethylbicyclo[2.2.2]octan-5-one-2,3-dicarboximide. Kossakowski J; Hejchman E Acta Pol Pharm; 2003; 60(1):61-6. PubMed ID: 12848369 [TBL] [Abstract][Full Text] [Related]
6. Buspirone analogues. 2. Structure-activity relationships of aromatic imide derivatives. New JS; Yevich JP; Eison MS; Taylor DP; Eison AS; Riblet LA; VanderMaelen CP; Temple DL J Med Chem; 1986 Aug; 29(8):1476-82. PubMed ID: 2874226 [TBL] [Abstract][Full Text] [Related]
7. Tandospirone suppresses impulsive action by possible blockade of the 5-HT1A receptor. Ohmura Y; Kumamoto H; Tsutsui-Kimura I; Minami M; Izumi T; Yoshida T; Yoshioka M J Pharmacol Sci; 2013; 122(2):84-92. PubMed ID: 23707971 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XXII. Derivatives of 1-methoxy-5-bicyclo[2.2.2]-oct-5-one-2,3-dicarboximide. Kossakowski J; Jarocka-Wierzba M Acta Pol Pharm; 2003; 60(5):367-74. PubMed ID: 15005420 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XVII. Derivatives of 1-ethoxybicyclo[2.2.2]-oct-5-one-2,3-dicarboximide. Kossakowski J; Jarocka M Farmaco; 2001 Oct; 56(10):785-9. PubMed ID: 11718272 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XV. Derivatives of 2-ethyl-1.4-dimethoxy-dibenzo[e.h]bicyclo[2.2.2] octane-2.3-dicarboximide. Kossakowski J; Maleszewska E Acta Pol Pharm; 2000 Nov; 57 Suppl():47-50. PubMed ID: 11293262 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of new n-substituted cyclic imides with potential anxiolytic activity. XVIII. Derivatives of 1-bromo-dibenzo[e.h]bicyclo[2.2.2] octane-2.3-dicarboximide. Kossakowski J; Perliński M Acta Pol Pharm; 2001; 58(4):257-62. PubMed ID: 11693729 [TBL] [Abstract][Full Text] [Related]
12. Investigations on the synthesis and properties of some N-[4-phenyl(2-pyrimidinyl)-1-piperazinyl]alkyl (hydroxyalkyl)-3,4-pyridinedicarboximides. Sladowska H; Potoczek J; Rajtar G; Sieklucka-Dziuba M; Zółkowska D; Kleinrok Z Acta Pol Pharm; 1996; 53(6):417-24. PubMed ID: 9415216 [TBL] [Abstract][Full Text] [Related]
13. [A new approach to innovating selective anxiolytics: pharmacological profile of a novel 5-HT1A agonist (tandospirone)]. Sasa M Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr; 17(2):53-9. PubMed ID: 9201724 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological screening of some N,N'-bis-[4-(4-aryl-1-piperazinyl)butyl]-substituted derivatives of 1,8-dimethylbicyclo-[2.2.2]oct-7-ene-2,3,5,6-tetracarboxydiimide. Turło J; Zawadowski T; Rump S; Jakowicz I; Gidyńska T; Gałecka E Pol J Pharmacol; 1994; 46(5):451-5. PubMed ID: 7894533 [TBL] [Abstract][Full Text] [Related]
16. Effect of 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), a novel 5-HT1A-receptor agonist, on aggressive behavior and marble burying behavior in mice. Abe M; Nakai H; Tabata R; Saito K; Egawa M Jpn J Pharmacol; 1998 Mar; 76(3):297-304. PubMed ID: 9593223 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of SM-3997: a new anxioselective anxiolytic candidate. Shimizu H; Hirose A; Tatsuno T; Nakamura M; Katsube J Jpn J Pharmacol; 1987 Dec; 45(4):493-500. PubMed ID: 2895201 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XIV. Derivatives of 1.4-diethoxy-dibenzo[e.h]bicyclo[2.2.2]octane-2.3-dicarboximide. Kossakowski J; Maleszewska E Acta Pol Pharm; 2000 Nov; 57 Suppl():50-3. PubMed ID: 11293264 [TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics and pharmacodynamics of tandospirone in rats exposed to conditioned fear stress. Nishitsuji K; To H; Shimizu T; Yanase Y; Yamada T; Hara C; Mine K; Higuchi S Eur Neuropsychopharmacol; 2006 Jul; 16(5):376-82. PubMed ID: 16406508 [TBL] [Abstract][Full Text] [Related]
20. Effects of tandospirone, a 5-HT1A receptor-related anxiolytic, on the pressor response elicited by stimulation of the posterior hypothalamus in cats. Tsuji R; Ohno Y; Hirose A; Shimizu H; Tanaka H; Nakamura M Arch Int Pharmacodyn Ther; 1991; 311():131-43. PubMed ID: 1686389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]